Annual Drug Patent Expirations for AFINITOR+DISPERZ
Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AFINITOR DISPERZ.
The generic ingredient in AFINITOR DISPERZ is everolimus. One supplier is listed for this compound. Additional details are available on the everolimus profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
